TEVA PHARMA IND revenue breakdown overview

TEVA PHARMA IND revenue for the last year amounted to 13.34 B CHF, the most of which — 13.34 B CHF — came from its highest performing source at the moment, Generics, Innovative Medicines and Over-the-counter Products, the year earlier bringing 13.80 B CHF. The greatest contribution to the revenue figure was made by North America — last year it brought TEVA PHARMA IND 6.84 B CHF, and the year before that — 6.89 B CHF.